Research programme: Rett syndrome therapeutics - Vyant Bio
Alternative Names: ORAI-xxxxLatest Information Update: 27 Mar 2024
At a glance
- Originator Atomwise; StemoniX; Vyant Bio
- Developer Vyant Bio
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Rett syndrome